Phase II clinical trial of celecoxib (or nsaid) for prevention of sporadic colorectal adenomas
Ended Definitive Contract Awarded Last action
- Contract number
- HHS261995015
- Awardee
-
Preventive Medicine Institute UEI MKMCB9BPZKX8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- New York, NY 10021, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHS261995015?
HHS261995015 was awarded to Preventive Medicine Institute by National Cancer Institute (National Institutes of Health) on September 29, 2005.
How much is contract HHS261995015 worth?
The government has obligated $0 on HHS261995015.
Was contract HHS261995015 competed?
The extent of competition for HHS261995015 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award